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We describe previously published work as well as new 
data on the molecular biology of human T-cell leukemia 
virus (HTLV) and its associated disease, adult T-cell 
leukemia-lymphoma (ATLL). This specific kind of dis­
ease is endemic to certain areas of Japan and the Car­
ibbean, and several isolated cases have been described 
also in the United States, Israel, South America, and 
Africa. The disease is probably also endemic to Africa 
and South America, but sufficient studies of these areas 
have not been performed. We have molecularly cloned 
the HTL V genome and used the-viral DNA as a probe in 
a large molecular study of the DNAs of human hemato­
poietic malignancies. The results showed that HTL V 
sequences could be detected in the fresh leukemic cells 
of all cases of ATLL tested. 
The neoplastic cells are of clonal origin and contain 
one or few copies of integrated BTL V. Detailed compar­
ative analyses by restriction enzyme mapping of the 
proviral DNA in U.S., Japanese, Caribbean, and Israeli 
cases revealed that the viruses are almost indistinguish­
able. 
The DNA from neoplastic cells of other cases of he­
matopoietic neoplasias analyzed were negative for 
HTLV sequences with the exception of two. DNA from 
cells of a patient (MO) with a T-cell variant of hairy cell 
leukemia did contain a provirus only distantly related 
to HTLV (less than 10% of DNA sequence homology). 
The virus isolated from the MO cells has been designated 
HTLV-II. The second case was a patient with chronic 
myeloid leukemia whose cells contained exogenous DNA 
sequences distantly related to HTL V. 
Different fragments of the clones HTL V genome have 
been used to hybridize to DNA from uninfected normal 
tissues of several vertebrate species, including humans, 
in a search for cell-derived sequences related to the 
HTLV genome. No homologous sequences were found 
except sequences distantly related to the pol and env 
genes, indicating that HTL V does not carry a cellularly 
derived one gene. Surprisingly, however, infection of 
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normal human fresh T cells by HTL V transforms them 
into cells with permanent growth and with several other 
properties similar to neoplastic T cells. 
We have also studied the expression of viral and cel­
lular genes in fresh and cultured neoplastic cells from 
patients with ATLL. Several species of viral mRNAs 
are always detected in the cultured neoplastic cells, 
whereas in some fresh samples expression of normal 
mRN A was not detected. The lack of viral mRN A in 
some of the fresh sample suggested that the neoplastic 
transformation could be maintained without the expres­
sion of viral genes. Because T cells of patients with 
A TLL as well as cells transformed in vitro by HTL V do 
have a decreased or no requirement for T-cell growth 
factor (TCGF; IL-2) for growth in vitro and exhibit a 
high number of TCGF cell surface receptors, we hypoth­
esized that BTL V infection may involve the transcrip­
tional activation of the TCGF gene concomitant with 
TCGF-induced persistent cell proliferation. However, 
only low-level expression of the TCGF gene was found 
in 2 of 5 cell lines and in none of the two fresh samples. 
Thus autostimulation by TCGF of one cell interacting 
with its own receptor cannot be the mechanism for ini­
tiation or maintenance of the abnormal growth induced 
by HTL V . We also analyzed the RN As of the HTL V­
infected cells for the expression of various one genes. 
None of the one genes tested seemed to be transcription­
ally activated in the fresh leukemic cells, with the ex­
ception of the sis gene, which is expressed at high level 
in two neoplastic cell lines (HUT 102 and MO) infected 
with HTLV-I and HTLV-II, respectively. 
Type C retroviruses have been identified as causative agents 
of leukemia and lymphoma in several animal species [1]. Two 
major classes of leukemia viruses can be distinguished with 
respect to the length of time in which they induce disease when 
inoculated in the animals. The acute leukemia viruses induce 
neoplasia in a few weeks, whereas the chronic leukemia viruses 
generally require at least a few months. The genome of the 
acute leukemia viruses contains a set of nucleotide sequences 
called one genes that have been acquired by recombination of 
the viral genome with a cellular sequence of the host of origin. 
The viral one genes are responsible for induction and mainte­
nance of the transformed phenotype in vivo and in vitro [2]. 
The neoplasias induced by the acute leukemia viruses are 
polyclonaL The chronic leukemia viruses represent the most 
frequent cause of leukemia-lymphoma in nature. They do not 
carry an one gene, they cause monoclonal diseases, and for 
most of them, the mechanism of leukemogenesis is unknown. 
In B-cell lymphoma and in erythroblastosis induced by the 
chronic virus avian leukosis virus (AL V), one pathogenetic step 
appears to be the integration of the viral promoter sequence in 
the vicinity of cellular one genes c-mye and c-erb B, respectively 
[3,4]. The c-mye and c-erb genes are the cellular homologues of 
the viral one genes of the avian myelocytomatosis virus (MC29) 
and the avian erythroblastosis virus. 
The human T-cell leukemia-lymphoma virus (HTLV) is the 
first retrovirus of humans as well as the first to be associated 
648 FRANCHINI, WONG-STAAL, AND GALLO 
with a specific type of human malignancy (for a recent review 
see [5]). The first isolates were obtained from U. S. patients 
(CR and MB) with advanced forms of cutaneous T·cell lym­
phoma and leukemia, respectively [6,7]. Seroepidemiologic data 
[8] revealed that there was a strict correlation between the 
presence of natural antibodies against the HTL V major core 
proteins (p24, p19) and a clinical syndrome termed adult T-cell 
leukemia·lymphoma (ATLL) first described in Japan [9]. The 
features of this clinical entity were characterized by an aggres­
sive course, frequent disseminated skin lesions, hepatospleno­
megaly, hypercalcemia, and the presence of circulating pleo­
morphic multinucleated lymphocytes. The predominant leu­
kemic cell population usually display phenotype markers 
(OKT4+, OKT3+, erythrocyte-rosette-positive) of mature T 
cells. HTL V was subsequently found to be endemic to the 
Caribbean basin [10]. The disease associated with HTLV in 
the Caribbean has been described as T-Iymphosarcoma cell 
leukemia (T-LCL). ATLL and T-LCL clearly are the same 
disease and henceforth will all be termed A TLL. A TLL is a 
clonal disease [11], and therefore, HTLV appears to belong to 
the class of the chronic leukemia viruses. However, paradoxi­
cally, HTLV can immortalize normal human T cells in vitro 
[12], a property usually ascribed to acute leukemia viruses. 
Transmission of HTLV to normal human T cells can be 
obtained by cocultivation of HTLV -positive T-cell lines ex­
posed to lethal doses of x·ray or mitomycin-C with normal cord 
blood T cells. The recipient cells acquire features of the neo­
plastic donor cells: (1) decreased requirement of exogenous T­
cell growth factor (TCGF) for growth and, in some cases, 
complete TCGF independence, (2) increased growth rate, (3) 
increased number of TCGF receptors (TAC) and transferrin 
receptors, and (4) some show phenotypical change to multinu­
clear giant cells and/or mononucleated cells with lobulated 
nuclei, both resembling the phenotype of many of the leukemic 
cells of patients with ATLL. 
We have attempted to investigate the possible mechanism of 
HTL V transformation in vivo and in vitro by asking first 
whether the expression of viral genes is necessary for initiation 
and/or maintenance of neoplastic transformation. Second, 
since the leukemic cells seem to be monoclonal, we investigated 
if the transcriptional activation of cellular one genes might be 
involved in the pathogenesis of the disease. Third, since both 
the primary leukemic T -cell lines established from patients and 
the infected cord blood T cells often grow independently of 
exogenous TCGF, we analyzed whether HTLV infection can 
induce increased expression of TCGF in fresh and cultured 
leukemic cells. Finally, we studied the expression of several 
human homologues of viral one genes in fresh and cultured 
leukemic cells. 
MATERIALS AND METHODS 
Isolation of Peripheral Blood Mononuclear Cells 
Heparinized peripheral blood is centrifuged at 1000 r/min for 10 min 
in a clinical centrifuge. The plasma is discarded, and the remaining 
cell pellet is diluted 1:10 with PBS and layered on 10 ml of LSM. The 
sample is centrifuged at 3000 r/min for 10 min, and the white interphase 
containing mononuclear cells is recovered. The cells are washed twice 
with 50 ml of PBS and pelleted by centrifugation at 2000 r/min for 10 
min. 
DNA Extraction and DNA Blotting 
The cells are suspended in 100x the volume of TNE buffer (Tris 10 
mM, NaCI 0.1 M, and EDTA 10 mM) and lysed by adding sodium 
dodecyl sulfate (final concentration 1 % ) . Proteinase K is added at a 
concentration of 0.2 mg/ml, and the DNA is incubated at 37°C over­
night. The DNA is extracted twice with phenol-clorophorm 1:1, 
equilibrated with 50 mM Tris, pH 9, precipitated with two volumes of 
ethanol, and resuspended in 10 mM Tris, pH 7.5. Restriction enzyme 
cleavages are performed according to the conditions suggested by the 
supplier on aliquots of 30 Ilg of DNA . The DNA samples are electro-
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phoresced on 1 % agarose gel and transferred to nitrocellulose as pre­
viously described (12). 
RNA Isolation and Blotting 
RNA was obtained from fresh lymphocytes by lysing the cells with 
8 M guanidine HCI as previously described [14). The RNAs were 
selected on oligo-T cellulose to enrich for poly A-containing molecules. 
The poly A + RNAs were dissolved in a solution containing 2.2 M 
formaldehyde, 50% formamide at 60·C and applied to a 1.2% agarose 
gel in 2.2 M formaldehyde. The electrophoresis was performed at 30 V 
overnight. The RNA was electrophoretically transferred to a gene­
screen membrane by using a Bio-rad cell at 10 V overnight. 
Preparation of Subgenomic HTL V Fragments 
The DNA of the recombinant A WESS phage 372-3 containing the 
HTLV·I prototype DNA was digested with various restriction enzymes 
and run on agarose gel to separate DNA fragments of different size. 
Slices of the agarose gel were obtained in correspondence of the desired 
DNA fragments. The DNA was electroeluted from the agarose slices at 
100 V for 1 h in a dialysis membrane. The DNA contained in the 
dialysis membrane was removed and purified by phenol extraction. 
Several fragments were originated corresponding to the gag gene (Sma! 
fragment of 1 kb), pol gene (HindIII 1 K fragment), env (2.4 kb Cla/ 
Hind fragment), and finally, a l-kb PstI-smaI fragment corresponding 
to the pX region only. The DNAs were labeled by nick translation with 
32P_dCTP. 
Nucleic Acid Hybridization 
Hybridizations of the filters with bound DNA or RNA were carried 
out in 3x standard saline citrate (SSC) (NaCI/Cit; IX NaCI/Cit = 0.15 
M NaC1/0.015 M sodium citrate), 5x Denhardt's solution (IX Den­
hardt's solution = 0.02% bovine serum albumine/0.02% Ficoll/0.02% 
polyvinylpyrrolidone), 50% formamide at 37·C for 12 h. Less stringent 
hybridization conditions were obtained increasing the salt concentra­
tion to 5x SSC. The filters were washed either in standard conditions: 
0.5x SSC, 0.1% sodium dodecyl sulfate (SDS) at 60·C or in less 
stringent conditions: 5x SSC, 0.1% SDS at 60·C. The filters were 
auto radiographed at -70·C for 24 h or more using Kodak XR film and 
Dupont Cronex Lightning Plus screens. 
RESULTS AND DISCUSSION 
Probes representing the long terminal repeats (LTR) and the 
envelope gene of both HTLV-I and HTLV-II [15,16] have been 
used in the examination of DNA from human hematopoietic 
malignancies for homologous sequences. Of 103 cases tested 
([11] and our unpublished results with B Hahn and H Guo et 
al) (see Table 1),14 were positive for the presence of HTLV-I 
TABLE I. HTL V-I and HTL V-II proviruses in human hematopoietic 
neoplastic fresh cell DNAs 
Disease 
ATLL (USA)" 
ATLL (Japan)" 
ATLL (Caribbean)" 
ATLL (Brazil)a 
AML 
AMML 
CML 
ALL 
CTCL 
Others 
HCL 
Number of HTLV-posi-
cases tive 
3 3 
8 8 
2 2 
1 1 
31 0 
3 0 
9 Ib 
8 0 
8 0 
25 0 
5 0 
Average copy 
number 
1.5 
1.5 
3 or more 
3 
? 
Note: ATLL, adult T-cell leukemia· lymphoma; AML, acute myeloid 
leukemia; AMML, acute myelomomocytic leukemia; CML, chronic 
myeloid leukemia; CTCL, cutaneous T-cell lymphoma; HCL, hairy cell 
leukemia. 
" Many more cases of ATLL have been found positive for the 
presence of HTL V by various criteria: virus isolation, immunofluores­
cence, etc., but the proviral DNA has not been studied in such cases, 
usually for the lack of sufficient amount of fresh cells. 
h This case contains sequences distantly related to HTL V-I. 
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sequences in standard hybridization conditions that allow the 
detection of perfectly matched complementary DNA strands. 
All 14 patients displayed the clinical manifestations of ATLL. 
These DNAs contained from one to three proviral copies. Eight 
of the patients were born in Japan, and 2 were from the 
Caribbean. All 10 cases originated from endemic areas for 
HTL V -I. The other 4 samples represent sporadic cases of 
ATLL from the United States or elsewhere. We previously 
reported many other American cases from which cell lines have 
been established and virus isolated and/or whose sera contained 
antibodies to HTLV proteins [11]. Such cases are not included 
in Table I. These results refer exclusively to positive molecular 
hybridization with DNA from fresh uncultured leukemic cells. 
The other 89 hematopoietic neoplasms have been analyzed 
with less stringent hybridization conditions in order to uncover 
viruses distantly related to HTL V -I. Positive hybridization was 
found in one case of chronic myeloid leukemia and in a patient 
with hairy cell leukemia (HCL) from which HTLV-II has been 
isolated. Similar experiments have been performed using 
HTLV-II probes to test the same 89 cases of leukemias-lym­
phomas. None was positive for HTLV -II, including 5 additional 
cases of HCL. These data together indicate a tight association 
between HTLV-I and ATLL. On the contrary, such correlation 
has not been found between HTLV-II and HCL, possibly 
because HTL V-II has been isolated from a rare T-cell variant 
of HCL. 
We reported elsewhere [11] that the neoplastic cells of the 
ATLL patients examined seem to represent the clonal expan­
sion of a single infected cell. These data suggested that HTL V­
I might be a chronic leukemia virus without a cell-derived one 
gene. To verify this hypothesis, we utilized several fragments 
of the HTL V-I genome representing the gag, pol, env, and 2000-
nucleotides fragment corresponding to the 3' end of the viral 
genome, designated the pX region [16]. We hybridized these to 
DNA from uninfected cells of human and other vertebrate 
origin. Weak hybridization was detected with the pol and env 
probes with normal uninfected human DNA, suggesting that 
human DNA contains sequences very distantly related to these 
HTLV genes. None of the other probes detected any sequences 
in DNA of human or animal origin (Table 11). Because all the 
TABLE II. Hybridization of subgenomic DNA fragments of the HTL V 
genome with vertebrate DNAs 
______ D_N_A_s_o_u_rc_� ________ �g� 
Chicken 
Mouse 
Hamster 
Cat 
Japanese macaque 
Marmoset 
Celebes ape 
Human 
ND 
ND 
ND 
pol 
ND 
ND 
ND 
± 
enu pX 
± 
, All the DNA filters were processed in nonstringent hybridization 
and washing conditions as described in Materials and Methods. 
known viral one genes do have a cellular homologue in verte­
brate DNAs, we concluded that HTLV does not carry a cell­
derived one gene. These data are in agreement with the pub­
lished DNA sequence of HTLV [18]. 
In order to characterize the HTL V transcripts in the infected 
cells, we isolated the RNA of the cell lines indicated in Table 
III. MI, MJ, Hutl02, and UK produce the HTLV-I prototype, 
whereas the MO cell line is infected with HTLV-IL The RNAs 
of all cell lines contained several viral mRNA species, including 
a 9-kb mRNA that must represent the genomic read-through 
RNA and a 4-kb mRNA that contains sequences homologous 
to the envelope gene and the pX region and might codify for 
the envelope gene. Several other subgenomic mRNAs can be 
detected in most of the RNAs analyzed of the two DNA 
specimens from fresh samples studied; one (SD) contained 
several mRNA species, but one (HS) had no detectable viral 
transcripts. This finding suggests that viral expression in some 
cases might be restricted in vivo and that product(s) of viral 
gene(s) might not be required for the maintenance of the 
neoplastic state. However, viral sequences were expressed in 
all T cells transformed in vitro by HTLV. Thus one or more 
viral proteins may be needed to initiate neoplastic transfor­
mation. 
To study the expression of the TCGF gene, we utilized a 
recombinant clone containing the 1000 nucleotides of cDNA 
obtained from the human TCGF mRNA [19]. Only the primary 
cell line (Hutl02 and MO) of two patients infected with HTLV­
I and HTLV -II, respectively, expressed detectable levels of 
TCGF mRNA [20] (see Table III). Both the fresh cells analyzed 
were negative for TCGF expression. We therefore conclude 
that although both the fresh and the cultured cells do express 
high levels of TCGF receptor, we can rule out a simple auto­
stimulation mechanism that would explain the immortal 
growth of the neoplastic T cells. 
Finally, we examined also the expression patterns of the c­
myc, c-fes, c-sis, c-abl, c-Kras, c-Hras, and c- erb one genes in 
both fresh and cultured (HJ Horneff et aI, in preparation) 
leukemic cells. Table III shows that c-fes, c-abl, and c-erb gene 
expression was undetectable in all the RNAs analyzed, whereas 
the c-myc, c-Kras, and c-Hras genes were expressed at low level 
in all the samples tested, a finding not unexpected in view of 
previous results from our laboratory [21]. c-sis [22], recently 
identified [23,24] as the gene for platelet-derived growth factor 
(PDGF), was found expressed only in the HUT102 and MO 
cell lines. The meaning of the PDGF expression in these two 
cell lines remains obscure. Activation of cellular homologues of 
known retroviral one genes has been shown to occur in viral­
induced [3,4] or spontaneous tumors in several animal species, 
including humans (for a review see [25]). Our data suggest that 
HTL V infection in vitro and in some cases in vivo does not 
correlate with transcriptional activation of the cellular one 
genes that we have tested. However, it is possible that another 
coone gene not examined is specifically activated by HTLV 
infection. Further studies will be needed to ascertain whether 
HTLV integrates randomly in the cellular DNA or whether 
TABLE III. Viral and cellular gene expression in HTL V-infected cells 
RNA source 
Cell lines: 
MI 
MJ 
HutlO2 
UK 
MO· 
Fresh neoplastic cells: 
SD 
HS ---_ . . . 
Viral genes 
+ 
+ 
+ 
+ 
+ 
+ 
TCGF (lL-2) c-sis c-fes c-myc 
+ 
+ 
± + + 
ND ND 
± ± ND 
+ 
+ 
a The MO cell line is infected with HTLV-II. MO RNA was hybridized with HTLV-I1 probe. 
c-abl c-Hrasjc-Kras 
+ 
+ 
+ 
+ 
+ 
ND 
ND 
c-erb 
ND 
ND 
668 FRANCHINI, WONG-STAAL, AND GALLO 
there is(are) preferred integration site(s) that could lead to the 
activation of contiguous genes. 
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